Vig Pamela 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Vig Pamela
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-01-08$28.03/sh−1,408$39,472→ 29,905 total
Holdings
- 75,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.